These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6880160)

  • 1. [Morphological bases of the effect of verapamil on the heart in experimental acute coronary failure].
    Tereshchenko VP; Nizhenkovskaia IV
    Vrach Delo; 1983 May; (5):19-21. PubMed ID: 6880160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
    Tereshchenko VP
    Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective effect of verapamil in experimental myocardial ischaemia: an electron microscopic investigation.
    Georgescu L; Rottenberg N; Avram R; Potencz E; Dema E; Petraşcu-Stefanovici O; Lazăr E
    Morphol Embryol (Bucur); 1988; 34(4):277-80. PubMed ID: 2976891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphological criteria of the effectiveness of using kordaron and obzidan in experimental myocardial ischemia].
    Grigor'eva NN; Gichka SG; Stepaniuk GI; Degtiareva LV
    Vrach Delo; 1984 Oct; (10):91-3. PubMed ID: 6516320
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of agents used in the therapy of acute ischemic heart disease on the histomorphological changes in the myocardium in acute dystrophy].
    Nikulin AA; Chernov IP
    Farmakol Toksikol; 1979; 42(4):371-6. PubMed ID: 477957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphofunctional analysis of the efficacy of verapamil in experimental ischemia].
    Bratus' VV; Sergienko OV; Bezus'ko AG; Shavaran SS
    Vrach Delo; 1989 Jul; (7):69-72. PubMed ID: 2800508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of verapamil on the damage caused by coronary insufficiency. Experimental research].
    Ferrari R; Visioli O; Nayler WG
    Boll Soc Ital Cardiol; 1978; 23(10):1675-81. PubMed ID: 261832
    [No Abstract]   [Full Text] [Related]  

  • 8. [The anti-ischemic properties of verapamil and its effect on myocardial functional potentials in coronary artery occlusion].
    Paperno AA; Kovalev GV; Gurbanov KG
    Farmakol Toksikol; 1991; 54(2):26-8. PubMed ID: 1884790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic changes in the myocardium in experimental infarct treated with benzofurocaine].
    Grigor'eva NN; Stepaniuk GI; Ishchenko VE; Slyn'ko EI
    Vrach Delo; 1988 Aug; (8):36-8. PubMed ID: 3206882
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of a new phenylalkyl taurine derivative on the size of the necrotic area in experimental myocardial infarct in rats].
    Sapronov NS; Torkunov PA; Eliseev VV; Krylova IB; Evdokimova NR
    Patol Fiziol Eksp Ter; 1999; (4):19-20. PubMed ID: 10598458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphological principles of acute and chronic myocardium insufficiency].
    Meessen H
    Verh Dtsch Ges Pathol; 1967; 51():3-66. PubMed ID: 4174695
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
    Syroïd DV; Sokrut VM; Shvyrenko IR
    Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of coronary artery occlusion and reperfusion for the discovery of novel antiischemic and antiinflammatory drugs for the heart.
    Wayman NS; McDonald MC; Chatterjee PK; Thiemermann C
    Methods Mol Biol; 2003; 225():199-208. PubMed ID: 12769489
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of hypercholesterolemia on the macroergic content and size of necrotic area in the heart muscle in acute coronary occlusion in rabbits].
    Irgashev ShB; Iuldashev NM
    Patol Fiziol Eksp Ter; 1987; (3):62-4. PubMed ID: 3627838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
    Vasilevskaia TA; Litvitskiĭ PF
    Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The activity of mitochondrial enzymes in the myocardium in chronic coronary failure during the administration of antianginal agents].
    Voronkov GS; Evstratova IN
    Eksp Klin Farmakol; 1992; 55(6):17-9. PubMed ID: 1305865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicordin--a new drug in the treatment of coronary heart disease.
    Samochowiec L; Wójcicki J; Gregorczyk K; Szmatloch E
    Mater Med Pol; 1974; 6(4):298-300. PubMed ID: 4453155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Eleutherococcus on the subcellular structures of the heart in experimental myocardial infarct].
    Afanas'eva TN; Lebkova NP
    Biull Eksp Biol Med; 1987 Feb; 103(2):212-5. PubMed ID: 3814806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of verapamil and nitroglycerin on experimental occlusion- reperfusion-induced myocardial infarction in rabbits].
    Shvilkin AV; Afonskaia NI; Sadretdinov SM; Cherpachenko NM; Levitskiĭ DO; Ruda MIa
    Kardiologiia; 1991 Jan; 31(1):15-7. PubMed ID: 1904510
    [No Abstract]   [Full Text] [Related]  

  • 20. [The verapamil correction of postresuscitation damages to the heart].
    Korpacheva OV; Dolgikh VT
    Anesteziol Reanimatol; 1996; (5):48-51. PubMed ID: 9027256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.